Author

Eleonora A.M. Festen

TNF?-ANTAGONIST USE AND MUCOSAL INFLAMMATION ARE ASSOCIATED WITH INCREASED INTESTINAL EXPRESSION OF SARS-COV-2 HOST PROTEASE TMPRSS2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TNF?-ANTAGONIST USE AND MUCOSAL INFLAMMATION ARE ASSOCIATED WITH INCREASED INTESTINAL EXPRESSION OF SARS-COV-2 HOST PROTEASE TMPRSS2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Eleonora A.M. Festen  et al.

GUT MICROBIAL CHANGES IN RESPONSE TO VEDOLIZUMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
GUT MICROBIAL CHANGES IN RESPONSE TO VEDOLIZUMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Eleonora A.M. Festen  et al.

Item 1 - 2 / 2
1